Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With Hypertension
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160212
- Locations
- 🇭🇺
Site 805, Budapest, Hungary
🇧🇬Site 957, Sofia, Bulgaria
🇭🇺Site 804, Pecs, Hungary
Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart Failure
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Registration Number
- NCT00160134
- Locations
- 🇩🇪
Site 1, Bad Nauheim, Germany
Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal Women
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00160264
- Locations
- 🇪🇸
Site 3, Barcelona, Spain
🇪🇸Site 2, Barcelona, Spain
🇪🇸Site 1, Barcelona, Spain
Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II Diabetes
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 440
- Registration Number
- NCT00160160
- Locations
- 🇳🇴
Site 41, Skedsmokorset, Norway
🇳🇴Site 44, Horten, Norway
🇳🇴Site 43, Alesund, Norway
Efficacy and Safety of Moxonidine in Indian Patients
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2009-01-30
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00160277
- Locations
- 🇮🇳
Site 3, New Delhi, India
🇮🇳Site 1, Jubillee Hills Hyderabad, India
🇮🇳Site 2, Mangalore, India
Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular Neurotomy
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2006-12-22
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 20
- Registration Number
- NCT00160238
- Locations
- 🇫🇷
Site 1, Marseille, France
Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory Conversion
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 240
- Registration Number
- NCT00160199
- Locations
- 🇺🇸
Site 7, Baltimore, Maryland, United States
🇺🇸Site 16, Reno, Nevada, United States
🇺🇸Site 14, Aventura, Florida, United States
Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-03-31
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00160186
- Locations
- 🇸🇪
Site 6, Stockholm, Sweden
🇫🇮Site 10, Tampere, Finland
🇩🇰Site 9, Odense, Denmark
Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 97
- Registration Number
- NCT00160290
- Locations
- 🇪🇸
Site 6, Granada, Spain
🇪🇸Site 2, Barcelona, Spain
🇪🇸Site 5, Huesca, Spain
Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-03-12
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 454
- Registration Number
- NCT00160316
- Locations
- 🇷🇴
Site 42, Bucharest, Romania
🇷🇴Site 43, Bucharest, Romania
🇷🇴Site 44, Bucharest, Romania
© Copyright 2024. All Rights Reserved by MedPath